Polycitra-LC Interactions
There are 255 drugs known to interact with Polycitra-LC (citric acid/potassium citrate/sodium citrate), along with 11 disease interactions. Of the total drug interactions, 104 are major, 101 are moderate, and 50 are minor.
- View Polycitra-LC disease interactions (11)
Medications known to interact with Polycitra-LC
Note: Showing generic names only.
- acetohexamide
- acrivastine
- aliskiren
- alprazolam
- aluminum carbonate
- aluminum hydroxide
- amiloride
- amitriptyline
- amoxapine
- amphetamine
- amprenavir
- aspirin
- atazanavir
- atropine
- axitinib
- azatadine
- azilsartan medoxomil
- bacampicillin
- belladonna
- benazepril
- benzphetamine
- benztropine
- biperiden
- bosutinib
- bromfenac
- brompheniramine
- candesartan
- captopril
- carbinoxamine
- carbonyl iron
- cefditoren
- cefpodoxime
- cefuroxime
- ceritinib
- chlorcyclizine
- chlordiazepoxide
- chlorpheniramine
- chlorpromazine
- chlorpropamide
- choline salicylate
- cinoxacin
- ciprofloxacin
- clemastine
- clidinium
- clobazam
- clomipramine
- clonazepam
- clorazepate
- clozapine
- cyclizine
- cyclobenzaprine
- cyproheptadine
- dabigatran
- dabrafenib
- daprodustat
- darifenacin
- dasatinib
- demeclocycline
- desipramine
- dexbrompheniramine
- dexchlorpheniramine
- dextroamphetamine
- diazepam
- diclofenac
- dicyclomine
- diflunisal
- digitoxin
- digoxin
- dihydroxyaluminum sodium carbonate
- dimenhydrinate
- diphenhydramine
- disopyramide
- divalproex sodium
- doxepin
- doxepin topical
- doxycycline
- doxylamine
- drospirenone
- duloxetine
- enalapril
- enalaprilat
- enoxacin
- ephedrine
- ephedrine nasal
- eplerenone
- eprosartan
- erlotinib
- erythromycin
- estazolam
- etodolac
- fenoprofen
- ferric maltol
- ferrous fumarate
- ferrous gluconate
- ferrous sulfate
- finerenone
- flavoxate
- flecainide
- fluphenazine
- flurazepam
- flurbiprofen
- fosinopril
- ibuprofen
- imipramine
- indomethacin
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- irbesartan
- iron bisglycinate
- iron polysaccharide
- iron protein succinylate
- ma huang
- magnesium salicylate
- maprotiline
- mecamylamine
- meclizine
- meclofenamate
- mefenamic acid
- meloxicam
- memantine
- mepenzolate
- mesoridazine
- methamphetamine
- methdilazine
- methenamine
- methotrexate
- methotrimeprazine
- methscopolamine
- mexiletine
- midazolam
- minocycline
- misoprostol
- moexipril
- molindone
- moxifloxacin
- multivitamin with iron
- multivitamin with iron and fluoride
- multivitamin, prenatal
- mycophenolate mofetil
- mycophenolic acid
- pazopanib
- peppermint oil
- perindopril
- perphenazine
- pexidartinib
- phenindamine
- phenylbutazone
- phenytoin
- pimozide
- piroxicam
- ponatinib
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- protriptyline
- pseudoephedrine
- pyrilamine
- salsalate
- scopolamine
- sodium salicylate
- sodium thiosalicylate
- solifenacin
- sparfloxacin
- sparsentan
- spironolactone
- sulindac
- tacrolimus
- telmisartan
- temazepam
- tetracycline
- thiethylperazine
- thioridazine
- thiothixene
- tipranavir
- tolazamide
- tolbutamide
- tolmetin
- tolterodine
- tolvaptan
- trandolapril
- triamterene
- triazolam
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimethoprim
- trimipramine
- tripelennamine
- triprolidine
- trospium
- trovafloxacin
Polycitra-LC disease interactions
There are 11 disease interactions with Polycitra-LC (citric acid/potassium citrate/sodium citrate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- UTI
- dehydration
- familial periodic paralysis
- hyperkalemia
- renal dysfunction
- GI irritation
- acid/base balance
- alkalosis
More about Polycitra-LC (citric acid/potassium citrate/sodium citrate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Citric acid/sodium citrate
Citric acid/sodium citrate systemic is used for alkylating agent cystitis, urinary alkalinization ...
Sodium bicarbonate
Sodium bicarbonate systemic is used for acidosis, alkylating agent cystitis, asystole, diabetic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.